SEELOS THERAPEUTICS, INC. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Seelos Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Seelos Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -13.1 %, a 103% decline year-over-year.
  • Seelos Therapeutics, Inc. annual Return On Equity for 2023 was 115 %.
  • Seelos Therapeutics, Inc. annual Return On Equity for 2022 was -425 %, a 283% decline from 2021.
  • Seelos Therapeutics, Inc. annual Return On Equity for 2021 was -111 %, a 71.3% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -13.1 -473 -103% Apr 1, 2024 Jun 30, 2024
Q1 2024 75.2 +10.4K Jan 1, 2024 Mar 31, 2024
Q4 2023 115 +540 Oct 1, 2023 Dec 31, 2023
Q3 2023 188 +427 Jul 1, 2023 Sep 30, 2023
Q2 2023 460 +605 Apr 1, 2023 Jun 30, 2023
Q1 2023 -10.3K -10.2K -10814% Jan 1, 2023 Mar 31, 2023
Q4 2022 -425 -314 -283% Oct 1, 2022 Dec 31, 2022
Q3 2022 -240 -141 -142% Jul 1, 2022 Sep 30, 2022
Q2 2022 -145 -13.2 -9.99% Apr 1, 2022 Jun 30, 2022
Q1 2022 -94.3 +260 +73.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -111 +276 +71.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -98.9 +818 +89.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -132 +518 +79.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -354 +193 +35.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -387 +1.42K +78.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -917 +311 +25.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -650 -74.2K -101% Apr 1, 2020 Jun 30, 2020
Q1 2020 -547 -2.58K -127% Jan 1, 2020 Mar 31, 2020
Q4 2019 -1.81K -1.92K -1728% Oct 1, 2019 Dec 31, 2019
Q3 2019 -1.23K -1.44K -692% Jul 1, 2019 Sep 30, 2019
Q2 2019 73.5K +77.5K Apr 1, 2019 Jun 30, 2019
Q1 2019 2.03K +2.38K Jan 1, 2019 Mar 31, 2019
Q4 2018 111 +101 +980% Oct 1, 2018 Dec 31, 2018
Q3 2018 208 +48.8 +30.7% Jul 1, 2018 Sep 30, 2018
Q2 2018 -3.99K -3.73K -1422% Apr 1, 2018 Jun 30, 2018
Q1 2018 -347 -293 -552% Jan 1, 2018 Mar 31, 2018
Q4 2017 10.3 -84.6 -89.1% Oct 1, 2017 Dec 31, 2017
Q3 2017 159 +46.7 +41.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -262 -417 -269% Apr 1, 2017 Jun 30, 2017
Q1 2017 -53.2 -270 -125% Jan 1, 2017 Mar 31, 2017
Q4 2016 94.9 -297 -75.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 112 -1.68K -93.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 155 +1.19K Apr 1, 2016 Jun 30, 2016
Q1 2016 216 +580 Jan 1, 2016 Mar 31, 2016
Q4 2015 392 +643 Oct 1, 2015 Dec 31, 2015
Q3 2015 1.79K +1.85K Jul 1, 2015 Sep 30, 2015
Q2 2015 -1.04K -987 -1885% Apr 1, 2015 Jun 30, 2015
Q1 2015 -364 -262 -256% Jan 1, 2015 Mar 31, 2015
Q4 2014 -251 -61.7 -32.5% Oct 1, 2014 Dec 31, 2014
Q3 2014 -53.5 +396 +88.1% Jul 1, 2014 Sep 30, 2014
Q2 2014 -52.4 +271 +83.8% Apr 1, 2014 Jun 30, 2014
Q1 2014 -102 +206 +66.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 -190 -0.58 -0.31% Oct 1, 2013 Dec 31, 2013
Q3 2013 -450 -347 -337% Jul 1, 2013 Sep 30, 2013
Q2 2013 -324 -186 -135% Apr 1, 2013 Jun 30, 2013
Q1 2013 -308 -97.2 -46.1% Jan 1, 2013 Mar 31, 2013
Q4 2012 -189 Oct 1, 2012 Dec 31, 2012
Q3 2012 -103 Jul 1, 2012 Sep 30, 2012
Q2 2012 -138 Apr 1, 2012 Jun 30, 2012
Q1 2012 -211 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.